Risk Factors for Suboptimal Adherence Identified by Patient-Reported Outcomes Assessments in Routine HIV Care at 2 North American Clinics-Reference-Cited by-同舟云学术

Risk Factors for Suboptimal Adherence Identified by Patient-Reported Outcomes Assessments in Routine HIV Care at 2 North American Clinics

Published:2022-09 Issue: Volume:Volume 16 Page:2461-2472
ISSN:1177-889X
Container-title:Patient Preference and Adherence
language:en
Short-container-title:PPA

Author:

Short Duncan^ORCID,Wang Xueqi^ORCID,Suri Shivali,Hsu Thomas K^ORCID,Jones Bryn,Fredericksen Rob J,Crane Heidi M,Musten Alexandra,Bacon Jean,Wang Yongwei,Gough Kevin A,Ramgopal Moti,Berry Jeff,Lober William B

Publisher

Informa UK Limited

Subject

Health Policy,Pharmacology, Toxicology and Pharmaceutics (miscellaneous),Social Sciences (miscellaneous),Medicine (miscellaneous)

Reference36 articles.

1. HIV-1 Antiretroviral Drug Therapy

Adherence to HIV treatment regimens: systematic literature review and meta-analysis

3. Adherence to Antiretroviral Therapy and Virologic Failure

4. Factors linked to transitions in adherence to antiretroviral therapy among HIV-infected illicit drug users in a Canadian setting

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Patient-Reported Outcomes After Switching to a 2-Drug Regimen of Fixed-Dose Combination Dolutegravir/Lamivudine: 48-Week Results from the SALSA Study;AIDS and Behavior;2024-09-03

2. Factors associated with incomplete adherence to integrase strand transfer inhibitor-containing single-tablet regimen among Japanese people living with HIV;Journal of Pharmaceutical Health Care and Sciences;2024-06-05

3. Impact of Treatment Adherence on Efficacy of Dolutegravir + Lamivudine and Dolutegravir + Tenofovir Disoproxil Fumarate/Emtricitabine: Pooled Week 144 Analysis of the GEMINI-1 and GEMINI-2 Clinical Studies;JAIDS Journal of Acquired Immune Deficiency Syndromes;2023-11-01